Cizzle Biotechnology Holdings PLC (CIZ) — Net Asset Quality Index
Cizzle Biotechnology Holdings PLC (CIZ) has a Net Asset Quality Index of -107.4% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX257.00K minus total liabilities of GBX533.00K yields net assets of GBX-276.00K. A higher index indicates a stronger, lower-leverage balance sheet. Check CIZ cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cizzle Biotechnology Holdings PLC Net Asset Quality Index Over Time (2006–2024)
This chart shows how Cizzle Biotechnology Holdings PLC's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of June 2025, the index stands at -107.4%, representing net assets of GBX-276.00K against total assets of GBX257.00K GBX. See CIZ working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Cizzle Biotechnology Holdings PLC (2006–2024)
The table below presents the year-by-year Net Asset Quality Index for Cizzle Biotechnology Holdings PLC from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Cizzle Biotechnology Holdings PLC stock valuation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 16.7% | GBX82.00K | GBX492.00K | GBX410.00K | ▼ -72.3 pp |
| 2023 | 89.0% | GBX1.51 Million | GBX1.69 Million | GBX186.00K | ▼ -5.8 pp |
| 2022 | 94.8% | GBX2.64 Million | GBX2.79 Million | GBX145.00K | ▲ +13.7 pp |
| 2021 | 81.1% | GBX937.00K | GBX1.16 Million | GBX218.00K | ▲ +45.6 pp |
| 2020 | 35.6% | GBX32.00K | GBX90.00K | GBX58.00K | ▼ -4.7 pp |
| 2019 | 40.2% | GBX6.63K | GBX16.48K | GBX9.85K | ▲ +285.0 pp |
| 2018 | -244.8% | GBX-235.00K | GBX96.00K | GBX331.00K | ▼ -268.8 pp |
| 2017 | 24.0% | GBX741.00K | GBX3.08 Million | GBX2.34 Million | ▼ -24.7 pp |
| 2016 | 48.7% | GBX2.19 Million | GBX4.49 Million | GBX2.30 Million | ▲ +1.5 pp |
| 2015 | 47.2% | GBX2.40 Million | GBX5.09 Million | GBX2.69 Million | ▼ -17.1 pp |
| 2014 | 64.3% | GBX5.05 Million | GBX7.85 Million | GBX2.81 Million | ▲ +6.5 pp |
| 2013 | 57.8% | GBX4.27 Million | GBX7.39 Million | GBX3.12 Million | ▼ -1.1 pp |
| 2012 | 58.9% | GBX4.79 Million | GBX8.14 Million | GBX3.35 Million | ▼ -8.1 pp |
| 2011 | 67.0% | GBX4.08 Million | GBX6.10 Million | GBX2.01 Million | ▼ -2.8 pp |
| 2010 | 69.8% | GBX3.54 Million | GBX5.08 Million | GBX1.53 Million | ▲ +25.8 pp |
| 2009 | 44.0% | GBX521.00K | GBX1.19 Million | GBX664.00K | ▼ -30.4 pp |
| 2008 | 74.4% | GBX1.67 Million | GBX2.24 Million | GBX574.00K | ▼ -2.4 pp |
| 2007 | 76.8% | GBX2.40 Million | GBX3.12 Million | GBX725.00K | ▲ +83.2 pp |
| 2006 | -6.4% | GBX-58.00K | GBX911.00K | GBX969.00K | — |